AtriCure (ATRC) Prelim. Q4 Revenue Tops Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Meta’s capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| AtriCure, Inc. (NASDAQ: ATRC) | Delayed: 59.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.30 | 52 Week High | $23.24 | |||
| Open | $59.30 | 52 Week Low | $13.44 | |||
| Day High | $59.30 | P/E | N/A | |||
| Day Low | $59.30 | EPS | $-0.45 | |||
| Volume | 2,794 | |||||
